Hyporesponsiveness to lipopolysaccharide alters the composition of NF-κB binding to the regulatory regions of inducible nitric oxide synthase gene

European Journal of Immunology

Volumn 28, Issue 9, 1998, Pages 2960-2970

  Goldring, Christopher E ^a   Reveneau, Sylvie ^a   Pinard, Dominique ^a   Jeannin, Jean François ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Lipopolysaccharide; Macrophage; Monocyte; Nitric oxide

Indexed keywords

CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; GENETIC TRANSCRIPTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 0031712326     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199809)28:09<2960::AID-IMMU2960>3.0.CO;2-B     Document Type: Article

References (46)

1. Johnston, C. A. and Greisman, S. E., Mechanisms of endotoxin tolerance. In Proctor, R. A. and Hinshaw, L. B. (Eds.) Handbook of Endotoxin, Vol. 2. Elsevier/North-Holland, New York 1985, pp 359-401.
2. Ziegler-Heitbrock, H. W. L., Molecular mechanism in tolerance to lipopolysaccharide. J. Inflamm. 1995. 45: 13-26.
3. Freudenberg, M. A. and Galanos, C., Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect. Immun. 1988. 56: 1352-1357.
4. LaRue, K. E. A. and McCall, C. E., A labile transcriptional repressor modulates endotoxin tolerance. J. Exp. Med. 1994. 180: 2269-2275.
5. Virca, G. D., Kim, S. Y., Glaser, K. B. and Ulevitch, R. J., Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. J. Biol. Chem. 1989. 264: 21951-21956.
6. Haas, J. G., Baeuerle, P. A., Riethmüller, G. and Ziegler-Heitbrock, H. W. L., Molecular mechanisms in down-regulation of tumor necrosis factor expression. Proc. Natl. Acad. Sci. USA 1990. 87: 9563-9567.
7. Ziegler-Heitbrock, H. W. L., Wedel, A., Schraut, W., Ströbel, M., Wendelgass, P., Sternsdorf, T., Baeuerle, P. A., Haas, J. G. and Riethmüller, G., Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J. Biol. Chem. 1994. 269: 17001-17004.
8. Severn, A., Xu, D., Doyle, J., Leal, L. M. C., O'Donnell, C. A., Brett, S. J., Moss, D. W. and Liew, F. Y., Preexposure of murine macrophages to lipopolysaccharide inhibits the induction of nitric oxide synthase and reduces leishmanicidal activity. Eur. J. Immunol. 1993. 23: 1711-1714.
9. Szabó, C., Thiemermann, C., Wu, C. C., Perretti, M. and Vane, J. R., Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc. Natl. Acad. Sci. USA 1994. 91: 271-275.
10. Chang, C. C., McCormick, C. C., Lin, A. W., Dietert, R. R. and Sung, Y. J., Inhibition of nitric oxide synthase gene expression in vivo and in vitro by repeated doses of endotoxin. Am. J. Physiol. 1996. 271: G539-G548.
11. Zingarelli, B., Halushka, P. V., Caputi, A. P. and Cook, J. A., Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock 1995. 3: 102-108.
12. Fahmi, H., Charon, D., Mondange, M. and Chaby, R., Endotoxin-induced desensitization of mouse macrophages is mediated in part by nitric oxide production. Infect. Immun. 1995. 63: 1863-1869.
13. Zhang, X. and Morrison, D. C., Lipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouse peritoneal macrophages. J. Exp. Med. 1993. 177: 511-516.
14. Zhang, X. and Morrison, D. C., Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages. J. Leukoc. Biol. 1993. 54: 444-450.
15. Jin, F.-Y., Nathan, C., Radzioch, D. and Ding, A., Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997. 88: 417-426.
16. Hiscott, J., Marois, J., Garoufalis, J., D'Addario, M., Roulston, A., Kwan, I., Pepin, N., Lacoste, J., Nguyen, H., Bensi, G. and Fenton, M., Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol. Cell. Biol. 1993. 13: 6231-6240.
17. Collart, M. A., Baeuerle, P. A. and Vassalli, P., Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol. Cell. Biol. 1990. 10: 1498-1506.
18. Sherman, M. P., Aeberhard, E. E., Wong, V. Z., Griscavage, J. M. and Ignarro, L. J., Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem. Biophys. Res. Commun. 1993. 191: 1301-1308.
19. Mülsch, A., Schray-Utz, B., Mordvintcev, P. I., Hauschuldt, S. and Busse, R., Diethyldithiocarbamate inhibits induction of macrophage NO synthase. FEBS Lett. 1993. 321: 215-218.
20. Goldring, C. E. P., Narayanan, R., Lagadec, P. and Jeannin, J.-F., Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-kappa B/Rel proteins. Biochem. Biophys. Res. Commun. 1995. 209: 73-79.
21. Griscavage, J. M., Wilk, S. and Ignarro, L. J., Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B. Proc. Natl. Acad. Sci. USA 1996. 93: 3308-3312.
22. Schmitz, M. L. and Baeuerle, P. A., The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J. 1991. 10: 3805-3817.
23. Kang, S. M., Tran, A.-C., Grilli, M. and Lenardo, M. J., NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science 1992. 256: 1452-1456.
24. Franzoso, G., Bours, V., Park, S., Tomita-Yamagucni, M., Kelly, K. and Siebenlist, U., The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 1992. 359: 339-342.
25. Ziegler-Heitbrock, H. W. L. and Ulevitch, R. J., CD14: cell surface receptor and differentiation marker. Immunol. Today 1993. 14: 121-125.
26. Goldring, C. E. P., Reveneau, S., Algarté, M. and Jeannin, J.-F., In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6. Nucleic Acids Res. 1996. 24: 1682-1687.
27. Xie, Q.-W., Kashiwabara, Y. and Nathan, C., Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 1994. 269: 4705-4708.
28. Fahmi, H. and Chaby, R., Desensitization of macrophages to endotoxin effects is not correlated with a down-regulation of lipopolysaccharide-binding sites. Cell. Immunol. 1993. 150: 219-229.
29. Fujita, T., Nolan, G. P., Ghosh, S. and Baltimore, D., Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev. 1992. 6: 775-787.
30. Kretzschmar, M., Meisterernst, M., Scheiderheit, C., Li, G. and Roeder, R. G., Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro. Genes Dev. 1992. 6: 761-774.
31. Sha, W. C., Liou, H.-C., Tuomanen, E. I. and Baltimore, D., Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 1995. 80: 321-330.
32. Sundstedt, A., Sigvardsson, M., Leanderson, T., Hedlund, G., Kalland, T. and Dohlsten, M., In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors. Proc. Natl. Acad. Sci. USA 1996. 93: 979-984.
33. Urban, M. B. and Baeuerle, P. A., The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences. New Biol. 1991. 3: 27-2889.
34. Kunsch, C., Ruben, S. M. and Rosen, C. A., Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol. Cell. Biol. 1992. 12: 4412-4421.
35. Lowenstein, C. J., Alley, E., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W. and Murphy, W. J., Macrophage nitric oxide synthase gene: two upstream regions mediate induction by Interferon gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 1993. 90: 9730-9734.
36. Xie, Q.-W., Whisnant, R. and Nathan, C., Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 1993. 177: 1779-1784.
37. Arenzana-Seisdedos, F., Thompson, J., Rodriguez, M., Bachelerie, F., Thomas, D. and Hay, R., Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol. Cell. Biol. 1995. 15: 2689-2696.
38. Martin, E., Nathan, C. and Xie, Q.-W., Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 1994. 180: 977-984.
39. Kamijo, R., Harada, H., Matsuyama, T., Bosland, M., Gerecitano, J., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., Mak, T. W., Taniguchi, T. and Vilcek, J., Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994. 263: 1612-1615.
40. Barber, S. A., Fultz, M. J., Salkowski, C. A. and Vogel, S. N., Differential expression of interferon regulatory factor 1 (IRF-1), IRF-2, and interferon consensus sequence binding protein genes in lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive macrophages. Infect. Immun. 1995. 6: 601-608.
41. Salkowski, C. A., Barber, S. A., Detore, G., R. and Vogel, S. N., Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes. J. Immunol. 1996. 156: 3107-3110.
42. 15N]nitrate in biological fluids. Anal. Biochem. 1982. 126: 131-138.
43. Marietta, M. A., Yoon, P. S., lyengar, R., Leaf, C. D. and Wishnok, J. S., Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988. 27: 8706-8711.
44. Srivastava, K. K., Cable, E. E. and Bonkovsky, H. L., Purifying nascent mRNA from nuclear run-on assays using guanidinium isothiocyanate. Biotechniques 1993. 15: 226-227.
45. Israël, N., Gougerot-Pocidalo, M. A., Aillet, F. and Virelizier, J. L., Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. J. Immunol. 1992. 149: 3386-3393.
46. Garrity, P. A. and Wold, B. J., Effects of different DNA polymerases in ligation-mediated PCR: enhanced genomic sequencing and in vivo footprinting. Proc. Natl. Acad. Sci. USA 1992. 89: 1021-1025.